Male Lower Urinary Tract Symptoms: BPH vs OAB?

Release date: May 16, 2011
Expiration date: May 15, 2012
Estimated time to complete this activity: 1 hour

Target Learners
This activity was designed for primary care physicians, nurse practitioners, physician assistants, and nurses, with interest in differential diagnosis of Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH).

Course Overview
This activity will focus on evaluating male lower urinary tract symptoms for differential diagnosis of OAB versus BPH. The faculty has incorporated evidence based approaches for treatment and management of OAB and BPH, and will provide indications for when it is appropriate to refer to specialists.

Learning Objectives
At the completion of this activity, the participant will be able to:

• Discuss the different types of lower urinary tract symptoms (LUTS) in men and their causes
• Implement the diagnostic evaluation of male LUTS into practice
• Assess the different treatment options for male LUTS and how they can be integrated into practice


Faculty
Stephen Kraus, MD, MS, FACS
Professor and Vice-Chairman
Department of Urology
School of Medicine UT Health Science Center
San Antonio, TX

Accreditation Statement
This activity was planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).  Interstate Postgraduate Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The University of North Texas Health Science Center at Fort Worth Office of Professional and Continuing Education is accredited by the American Osteopathic Association to award continuing medical education to physicians.

Credit Designation
The Interstate Postgraduate Medical Association designates this enduring material for a maximum 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 1 hour in AOA Category 2B CME credit hours.  Approval is currently pending.

IPMA is approved by the California Board of Registered Nursing, Provider Number 6971, for 1.2 contact hours.

Commercial Support
IPMA gratefully acknowledges Pfizer for providing an educational grant in support of this activity.

Faculty and Planners Disclosure Statement
As a provider dedicated to independent education and accredited by the ACCME, Interstate Postgraduate Medical Association (IPMA) must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. It is the policy of IPMA to require disclosure of the existence of any significant financial interest or other relationship a faculty member, planner, or a sponsor has with either the commercial supporter of this activity or the manufacturer(s) of any commercial product(s) discussed in an educational presentation.

Faculty Disclosures
The presenting faculty reported the following:

Stephen Kraus, MD, MS, FACS, Advisory Board, Consultant and Lecturer for Pfizer; Consultant for Laborie Medical

Planner Disclosures
No planners or staff who could influence the content of this activity have any relations with relevant commercial interests to disclose.


Independent Reviewer
Richard G. Roberts, MD, JD nothing to disclose.

Disclosure of Off-Label Use
The audience is advised that  this continuing medical education activity will not include reference(s) to unlabeled or unapproved uses of drugs or devices.

Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that the faculty are expressing the views of the Interstate Postgraduate Medical Association, University of North Texas Health Science Center, or any other company.

Peer Review
This activity has been reviewed by a physician of the target audience.

Method of Participation
There are no fees or pre-requisites for participating in and receiving credit for this online educational activity.  In order to obtain credit for participating in this activity during the period of May 16, 2011 through May 15, 2012, participants must:

  • Read the educational objectives and disclosure statements
  • Study the educational activity
  • Complete the online pre-test questions and score 70% or higher in the post-test
  • Complete the evaluation
  • Submit the evaluation and post-test online to IPMA

Credit will be issued only upon receipt of a post-test with a score of 70% or higher and a completed activity evaluation.  After submitting these forms, you will be able to print out your credit certificate.  This activity should take 1 hour to complete.

Hardware/Software Requirements:
Internet Explorer (version 7 recommended), Firefox 3.6+, Adobe Flash, PDF Reader.

Privacy Policy
At IPMA we care about providing you with tools and information to manage and protect your online privacy. IPMA retains records solely for keeping records in accordance with ACCME policies. We will not share your information with any other organizations. We will keep you informed of our CME activities.

Please email cmehelp@ipmameded.org if you do not want to receive any communications from us.

Copyright
All material on this website is protects by copyright. Copyright 2011 by IPMA. This also contains material copyrighted by 3rd parties.

Contact Information
IPMA
PO Box 5474
Madison, WI 53705
608.231.9045 fax 877.292.4489

cmehelp@ipmameded.org

Resources

sssoplogo

Successful Strategies to Support Your OAB Patients (SSSOP) is a multi-organizational education initiative designed to provide physicians and healthcare professionals with effective strategies targeted to support patients with overactive bladder issues and bladder health. Healthcare professionals may find these materials helpful to communicate with patients about urinary incontinence and bladder health. Several tools allow for personalization with your practice contact information.
Additional Resources arrow.png

American Urological Association
Management of BPH arrow.png
AUA Symptom Index for BPH and the Disease-Specific Quality-of-Life Question arrow.png
Additional Resources arrow.png

Start the Activity